Fampridine: Long-term benefits in walking in multiple sclerosis.
From the Departments of Rehabilitation Science, Neurology, and Neurosurgery, University at Buffalo, SUNY Buffalo, NY. sbennett@buffalo.edu.
Susan E
SE
Bennett
D015761:4-Aminopyridine / Q000627:therapeutic use*; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology*; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D016138:Walking / Q000502:physiology*
D026902:Potassium Channel Blockers; D015761:4-Aminopyridine